Sepha has achieved micro leak detection down to one micron (1μm) with the development of a new high performance leak tester for CCIT (Container Closure Integrity Testing) applications. Utilising the vacuum decay test method, the new Multi-Q HD unit takes integrity testing to the next level, enabling ultra-sensitive, non-destructive detection of defects in pharmaceutical containers. This enhanced testing functionality responds to demand from parenteral formats, which are experiencing unprecedented growth on the back of international Covid-19 vaccination programmes.

Innovative technology for clinical trials is now, more than ever, necessary to deliver decentralized trials (DCT) and enable design of hybrid protocols that support trial continuity and patient-centricity

AIXIAL GROUP becomes a leading mid-size, worldwide CRO with strong US and European presence and more than
1,000 employees.

COVID-19 testing labs can now skip RNA extraction, simplifying and accelerating workflows

Sepha, the Northern Ireland based specialist in pharmaceutical packaging and machinery, has launched a contract packaging service to meet rising demand for small batch production.

Protein Metrics (Cupertino, CA) and MOBILion Systems Inc. (Chadds Ford, PA) announce their strategic partnership to provide data analysis modules for Protein Metrics’ Byos software suite that work exclusively with MOBILion’s High-Resolution Ion Mobility (HRIM) Mass Spectrometry (MS) System. Combining best in class data analysis with the fastest, highest resolution analysis of multiple Critical Quality Attributes (CQA) to accelerate biotherapeutic drug development and enhance characterization capabilities that affect product quality, safety, and efficacy.

Belfast, UK, November 30, 2020: Sepha, a specialist in leak test solutions for the pharmaceutical packaging industry, will be introducing its newly patented 3D Leak Detection technology for pharmaceutical blister packs via two live online webinars on the 2nd and 3rd December 2020. Aimed at pharmaceutical manufacturers, the new technology incorporates a 3D sensor to provide volumetric measurement to assess the integrity of a range of pharmaceutical solid dose and flexible barrier packaging.

MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in specific brain regions that contribute to the early onset and progression of Parkinson’s disease.